February 26, 2020 / 9:52 PM / a month ago

BRIEF-Rhythm Pharmaceuticals On Feb 20, Entered Into Amendment No. 1 To Development And Manufacturing Services Agreement With Corden Pharma Brussels

Feb 26 (Reuters) - Rhythm Pharmaceuticals Inc:

* RHYTHM PHARMACEUTICALS - ON FEB 20, ENTERED INTO AMENDMENT NO. 1 TO DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT WITH CORDEN PHARMA BRUSSELS

* RHYTHM PHARMACEUTICALS INC - UNDER AMENDMENT, CORDEN WILL MANUFACTURE SETMELANOTIDE FOR CO

* RHYTHM PHARMACEUTICALS - IN AMENDMENT, TO MAKE MILESTONE PAYMENTS TO CORDEN FOR COMPLETION OF TESTING, VALIDATION OF BATCHES OF SETMELANOTIDE

* RHYTHM PHARMACEUTICALS INC - UNDER AMENDMENT, CORDEN WILL EMPLOY, AT CO'S EXPENSE, CERTAIN EMPLOYEES TO SUPPORT CORDEN'S WORK PURSUANT TO AMENDMENT Source text: (bit.ly/3acc7Cr) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below